Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
117.49
-0.26 (-0.22%)
Jul 10, 2025, 4:00 PM - Market closed
Encompass Health Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$123.38
Upside
+5.01%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy Reiterates $135 | Buy | Reiterates | $135 | +14.90% | Jun 5, 2025 |
| Keybanc | Keybanc | Buy Maintains $122 → $135 | Buy | Maintains | $122 → $135 | +14.90% | May 27, 2025 |
| UBS | UBS | Strong Buy Maintains $117 → $130 | Strong Buy | Maintains | $117 → $130 | +10.65% | Apr 28, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $110 → $125 | Buy | Maintains | $110 → $125 | +6.39% | Apr 28, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $116 → $135 | Strong Buy | Reiterates | $116 → $135 | +14.90% | Apr 28, 2025 |
| Keybanc | Keybanc | Buy Maintains $120 → $122 | Buy | Maintains | $120 → $122 | +3.84% | Apr 25, 2025 |
| Barclays | Barclays | Buy Maintains $118 → $129 | Buy | Maintains | $118 → $129 | +9.80% | Apr 25, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $110 | Buy | Reiterates | $110 | -6.38% | Feb 11, 2025 |
| Keybanc | Keybanc | Buy Maintains $117 → $120 | Buy | Maintains | $117 → $120 | +2.14% | Feb 10, 2025 |
| Barclays | Barclays | Buy Maintains $116 → $118 | Buy | Maintains | $116 → $118 | +0.43% | Feb 7, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $105 → $110 | Buy | Maintains | $105 → $110 | -6.38% | Oct 30, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $108 → $116 | Strong Buy | Reiterates | $108 → $116 | -1.27% | Oct 30, 2024 |
| Barclays | Barclays | Buy Maintains $109 → $116 | Buy | Maintains | $109 → $116 | -1.27% | Oct 29, 2024 |
| Keybanc | Keybanc | Buy Maintains $115 → $117 | Buy | Maintains | $115 → $117 | -0.42% | Oct 29, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $104 → $108 | Strong Buy | Maintains | $104 → $108 | -8.08% | Oct 14, 2024 |
| Keybanc | Keybanc | Buy Initiates $115 | Buy | Initiates | $115 | -2.12% | Oct 11, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.